Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial

INTRODUCTION: Antiplatelet therapy combining aspirin and clopidogrel is considered to be a key intervention for acute ischaemic minor stroke (AIMS) and transient ischaemic attack (TIA). However, the interindividual variability in response to clopidogrel resulting from the polymorphisms in clopidogre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiao-Guang, Zhu, Xiao-Qiong, Xue, Jie, Li, Zhi-Zhang, Jiang, Hua-Yu, Hu, Liang, Yue, Yun-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538075/
https://www.ncbi.nlm.nih.gov/pubmed/31123001
http://dx.doi.org/10.1136/bmjopen-2018-028595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538075/
https://www.ncbi.nlm.nih.gov/pubmed/31123001
http://dx.doi.org/10.1136/bmjopen-2018-028595

Ejemplares similares